Acetaminophen is used to reduce fever and relieve mild to moderate pain, such as headaches, muscle aches, and cold symptoms.[2] Tylenol is currently approved and in use across 145 indications[4].[1]
Tylenol is one of 1715 small molecule programs targeting Obesity. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
348 competitors in Solid Tumor
Tylenol
Yervoy
Nubeqa
Zejula
Augtyro
Paxil
Proleukin
Epivir
Carboplatin AUC-5
Soc
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
ACEPHEN
NDA NDA018060
Jan 1, 1982
NEOPAP
NDA NDA016401
Jan 1, 1982
TYLENOL
NDA NDA017756
Sep 12, 1983
ACETAMINOPHEN
NDA NDA018337
Mar 7, 1986
INJECTAPAP
NDA NDA017785
Jun 8, 1994
TYLENOL
NDA NDA019872
Jun 8, 1994
TYLENOL
NDA NDA019872
Jan 5, 1995
TYLENOL
NDA NDA019872
Jul 28, 1995
TYLENOL
NDA NDA019872
Aug 1, 1995
TYLENOL
NDA NDA019872
Jul 25, 2000
TYLENOL
NDA NDA019872
Jul 25, 2000
TYLENOL
NDA NDA019872
Jan 11, 2001
TYLENOL
NDA NDA019872
Feb 12, 2001
TYLENOL
NDA NDA019872
May 28, 2003
TYLENOL
NDA NDA019872
May 28, 2003
TYLENOL
NDA NDA019872
May 29, 2003
TYLENOL
NDA NDA019872
Aug 1, 2003
TYLENOL
NDA NDA019872
Mar 22, 2004
TYLENOL
NDA NDA019872
Apr 13, 2004
TYLENOL
NDA NDA019872
Nov 3, 2004
TYLENOL
NDA NDA019872
Feb 28, 2008
TYLENOL
NDA NDA019872
Jun 17, 2009
TYLENOL
NDA NDA019872
Sep 18, 2009
TYLENOL
NDA NDA019872
May 6, 2010
TYLENOL
NDA NDA019872
May 10, 2010
TYLENOL
NDA NDA019872
Nov 2, 2010
OFIRMEV
NDA NDA022450
Dec 23, 2011
TYLENOL
NDA NDA019872
Mar 26, 2013
TYLENOL
NDA NDA019872
Mar 28, 2013
TYLENOL
NDA NDA019872
Dec 20, 2013
TYLENOL
NDA NDA019872
Mar 6, 2014
TYLENOL
NDA NDA019872
Dec 12, 2014
TYLENOL
NDA NDA019872
Dec 23, 2014
TYLENOL
NDA NDA019872
Oct 28, 2015
ACETAMINOPHEN
NDA NDA204767
May 5, 2016
TYLENOL
NDA NDA019872
Aug 26, 2016
TYLENOL
NDA NDA019872
Jan 16, 2019
TYLENOL
NDA NDA019872
Apr 16, 2019
ACETAMINOPHEN
NDA ANDA211544
Jan 15, 2021
ACETAMINOPHEN
NDA NDA206610
Feb 18, 2021
ACETAMINOPHEN
NDA NDA204957
Jun 3, 2022
ACETAMINOPHEN
NDA NDA206968
Feb 28, 2023
ACETAMINOPHEN AND IBUPROFEN
NDA ANDA214836
Jan 18, 2024
ACETAMINOPHEN
NDA ANDA211544
Oct 22, 2025
ACETAMINOPHEN AND IBUPROFEN
NDA ANDA214836
Oct 22, 2025
ACETAMINOPHEN AND IBUPROFEN
NDA ANDA214836
Oct 22, 2025
ACETAMINOPHEN AND IBUPROFEN
NDA ANDA214836
Sources
Details
Patent Cliff
Nov 13, 2028
Earliest patent expiration — generic entry possible after this date